Crossmark

Serum PCSK9 level as a potential biomarker relating to age, cholesterol and predicting major adverse cardiovascular event risk in hemodialysis patients

Crossref DOI link: https://doi.org/10.1007/s11255-025-04776-9

Published Online: 2025-10-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yunxia

Chai, Wenxiu

Cai, Panpan

Xin, Ye

Shao, Jianbo
License Information

Text and Data Mining valid from 2025-10-20

Version of Record valid from 2025-10-20
More Information

Article History

Received: 18 June 2025

Accepted: 1 September 2025

First Online: 20 October 2025

Declarations

:

: The authors declare that there are no competing interests.

: The Ethics Committee of Handan Central Hospital approved this study; then the subjects provided informed consent.

: Not applicable.

Document is current

Any future updates will be listed below